This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

California Codifies Restrictions On Corporate Practice Of Medicine And Other Private Equity Arrangements With Providers

On October 6, 2025, California Governor Gavin Newsom signed Senate Bill 351 (SB 351 or the Bill) into law, codifying certain prohibitions on the corporate practice of medicine and the use of certain restrictive covenants...

United States Healthcare

WS

Winston & Strawn LLP

Take Notice: California Expands Healthcare Transaction Notification Regime

Just five days after tightening restrictions on the corporate practice of medicine for hedge funds and private equity groups, on October 11, 2025, California Governor Gavin Newsom signed...

United States Healthcare

WS

Winston & Strawn LLP

3rd Quarter 2025 Chapter 11, Healthcare And Real Estate Distress Indices

The latest Polsinelli-TrBK Distress Indices Report shows mixed distress trends across major sectors, with a sharp increase in health care distress, a rise in Chapter 11 filings and steady distress levels in real estate.

United States Healthcare

PL

Polsinelli LLP

M&A In GLP-1 Technology: Practical Recommendations And Best Practices

The GLP-1 revolution has rewritten the playbook for metabolic disease, and it's also reshaping dealmaking

United States Healthcare

FL

Foley & Lardner

CMS Finalizes Sweeping Reforms To Skin Substitute Payments Amid Rising Costs And Enforcement Activity

United States Healthcare

PL

Polsinelli LLP

Patients Over Profit Act: A Federal Inflection Point On Insurer-Provider Integration And What Comes Next

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Connecticut DSS Home Care Provider Registry: Employer Reporting Started October 1, 2025

United States Healthcare

PL

Polsinelli LLP

Ninth Circuit Upends USDA's Bioengineered Food Disclosure Requirements

United States Healthcare

WR

Wiley Rein

Don't Let The Stark Law Catch You Off Guard: Risk Remains Despite The Lull

United States Healthcare

PL

Polsinelli LLP

FDA Accelerates Again: The Second CNPV Cohort

United States Healthcare

HP

Hyman, Phelps, & McNamara

Rewriting The Rulebook: MHRA's Vision For Rare Disease Therapies

United States Healthcare

AP

Arnold & Porter

CMS Announces GENEROUS Model For Most Favored Nation Pricing In Medicaid

United States Healthcare

HP

Hyman, Phelps, & McNamara

Ninth Circuit Issues Significant Ruling On Bioengineered Food Disclosure Standard

United States Healthcare

PC

Perkins Coie LLP

FDA Considers Drug Pricing: Leadership Cites Consumer Cost As A Driver For Changes To Biosimilar Recommendations

United States Healthcare

FL

Foley & Lardner

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

The Patent Eligibility Restoration Act: Revisions To Section 101 Moving Closer To The Finish Line

PERA is hardly new; substantially similar laws were proposed in each year since 2022. But momentum may be growing

United States IP

UT

Upadhye Tang

Rewriting The Rulebook: MHRA's Vision For Rare Disease Therapies

A new policy paper released on 2 November 2025 sets out the MHRA's proposals on overhauling and transforming the UK regulation of rare therapies.

United States Healthcare

AP

Arnold & Porter

FDA Considers Drug Pricing: Leadership Cites Consumer Cost As A Driver For Changes To Biosimilar Recommendations

The U.S. Food and Drug Administration (FDA) has traditionally refrained from considering drug pricing — and for good reason. Scientific determinations of whether a regulated product...

United States Healthcare

FL

Foley & Lardner

When EPA Steps Back: How States Are Leading Enforcement Amid Deregulation – Prepare Your Company

United States Environment

SJ

Steptoe LLP

New York Attorney General Obtains $1.1 Million Settlement Over "Net Zero By 2040" Claims

United States Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

CMS Implements Major Drug Pricing Changes In CY 2026 Physician Fee Schedule Final Rule

United States Healthcare

HP

Hyman, Phelps, & McNamara

Executive Branch Focus On Federally Funded Inventions

United States Healthcare

CM

Crowell & Moring LLP

Samsung Biologics Completes Spin-Off And Launches Samsung Epis Holdings

United States Healthcare

GP

Goodwin Procter LLP

Filling The Gaps And Navigating Fine Lines: Regulatory Compliance Framework And Considerations For California Medical Spas

United States Healthcare

M

Mintz

See more

Healthcare

California Codifies Restrictions On Corporate Practice Of Medicine And Other Private Equity Arrangements With Providers

On October 6, 2025, California Governor Gavin Newsom signed Senate Bill 351 (SB 351 or the Bill) into law, codifying certain prohibitions on the corporate practice of medicine and the use of certain restrictive covenants...

United States Healthcare

WS

Winston & Strawn LLP

PR OSHA's New Penalty Framework For Workplace Safety Violations Increases Fines For Employers

Puerto Rico Occupational Safety and Health Administration (PR OSHA) has increased penalty amounts for workplace safety violations.

United States Employment

JL

Jackson Lewis P.C.

Take Notice: California Expands Healthcare Transaction Notification Regime

Just five days after tightening restrictions on the corporate practice of medicine for hedge funds and private equity groups, on October 11, 2025, California Governor Gavin Newsom signed...

United States Healthcare

WS

Winston & Strawn LLP

3rd Quarter 2025 Chapter 11, Healthcare And Real Estate Distress Indices

United States Healthcare

PL

Polsinelli LLP

M&A In GLP-1 Technology: Practical Recommendations And Best Practices

United States Healthcare

FL

Foley & Lardner

CMS Finalizes Sweeping Reforms To Skin Substitute Payments Amid Rising Costs And Enforcement Activity

United States Healthcare

PL

Polsinelli LLP

Patients Over Profit Act: A Federal Inflection Point On Insurer-Provider Integration And What Comes Next

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Connecticut DSS Home Care Provider Registry: Employer Reporting Started October 1, 2025

United States Healthcare

PL

Polsinelli LLP

Don't Let The Stark Law Catch You Off Guard: Risk Remains Despite The Lull

United States Healthcare

PL

Polsinelli LLP

See more

Food and Drugs Law

M&A In GLP-1 Technology: Practical Recommendations And Best Practices

The GLP-1 revolution has rewritten the playbook for metabolic disease, and it's also reshaping dealmaking

United States Healthcare

FL

Foley & Lardner

Patients Over Profit Act: A Federal Inflection Point On Insurer-Provider Integration And What Comes Next

For years, the conversation around health insurer consolidation and vertical integration has simmered through antitrust inquiries, oversight hearings, and policy papers.

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

The Patent Eligibility Restoration Act: Revisions To Section 101 Moving Closer To The Finish Line

PERA is hardly new; substantially similar laws were proposed in each year since 2022. But momentum may be growing

United States IP

UT

Upadhye Tang

Ninth Circuit Upends USDA's Bioengineered Food Disclosure Requirements

United States Healthcare

WR

Wiley Rein

Don't Let The Stark Law Catch You Off Guard: Risk Remains Despite The Lull

United States Healthcare

PL

Polsinelli LLP

FDA Accelerates Again: The Second CNPV Cohort

United States Healthcare

HP

Hyman, Phelps, & McNamara

CMS Announces GENEROUS Model For Most Favored Nation Pricing In Medicaid

United States Healthcare

HP

Hyman, Phelps, & McNamara

Ninth Circuit Issues Significant Ruling On Bioengineered Food Disclosure Standard

United States Healthcare

PC

Perkins Coie LLP

FDA Considers Drug Pricing: Leadership Cites Consumer Cost As A Driver For Changes To Biosimilar Recommendations

United States Healthcare

FL

Foley & Lardner

See more

Latest Videos

See more

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

WHLC Summit - Day Two Recording (Video)

SM

Sheppard Mullin Richter & Hampton

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

The Journey To Better Healthcare With Ben Kruger (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Upcoming Events

State Drug Price Transparency Laws And Prescription Drug Affordability Boards – 2025 Year-End Review Webinar

United States Healthcare

GP

Goodwin Procter LLP

BBS Connect At 44th Annual J.P. Morgan Healthcare Conference

United States Healthcare

BB

Bass, Berry & Sims

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech

United States Healthcare

AP

Arnold & Porter

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

NEHEN: Fundraising At Inflection Points: How To Get It Right

United States Healthcare

FH

Foley Hoag LLP

Navigating The Intersection Of Healthcare And Business Law

United States Healthcare

BB

Bass, Berry & Sims

Federal Circuit Bar Association Annual Dinner & Reception

United States Healthcare

FH

Foley Hoag LLP

Healthcare Enforcement Compliance Conference

United States Healthcare

BB

Bass, Berry & Sims

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More